CENTRAL NERVOUS SYSTEM INVOLVEMENT BY LEUKEMIA IN CHILDREN. I. RELATIONSHIP TO SYSTEMIC LEUKEMIA AND DESCRIPTION OF CLINICAL AND LABORATORY MANIFESTATIONS.
D000970:Antineoplastic Agents; D002493:Central Nervous System Diseases; D002648:Child; D019411:Clinical Laboratory Techniques; D004358:Drug Therapy; D006261:Headache; D006801:Humans; D007427:Intracranial Pressure; D007938:Leukemia; D015122:Mercaptopurine; D008727:Methotrexate; D009369:Neoplasms / Q000175:diagnosis* / Q000453:epidemiology*; D010211:Papilledema; D011241:Prednisone / Q000627:therapeutic use*; D014839:Vomiting
D000970:Antineoplastic Agents; D015122:Mercaptopurine; D011241:Prednisone; D008727:Methotrexate
ANTINEOPLASTIC AGENTS; CENTRAL NERVOUS SYSTEM DISEASES; CHILD; DIAGNOSIS, LABORATORY; DRUG THERAPY; HEADACHE; INTRACRANIAL PRESSURE; LEUKEMIA; MERCAPTOPURINE; METHOTREXATE; NEOPLASM DIAGNOSIS; NEOPLASM STATISTICS; PAPILLEDEMA; PREDNISONE, THERAPEUTIC; VOMITING